Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Spinelli

Showing results (271-280 of 407) with videos related to

Pageof 41
Sort By:
International Journal of Cancer|March 15, 1989
Pathologic prognostic factors for cutaneous malignant melanoma: the Western Canada Melanoma StudyA J Worth, R P Gallagher, J M Elwood, et al.
JAMA Network Open|December 7, 2020
Trends in Diagnosis Related Groups for Inpatient Admissions and Associated Changes in Payment From 2012 to 2016Ty J Gluckman, Kateri J Spinelli, Mansen Wang, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Gas-chromatographic analysis of busulfan for therapeutic drug monitoringL Embree, R B Burns, J R Heggie, et al.
Blood|September 6, 2003
Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractorinessMatthew D Seftel, Gershon H Growe, Tanya Petraszko, et al.
BMC Medical Genetics|November 18, 2009
Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphomaJohanna M Schuetz, Amy C MaCarthur, Stephen Leach, et al.
American Journal of Industrial Medicine|July 8, 2010
Exposure to anesthetic gases and congenital anomalies in offspring of female registered nursesKay Teschke, Zenaida Abanto, Laura Arbour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancyG L Phillips, J D Shepherd, M J Barnett, et al.
The New England Journal of Medicine|December 23, 1999
Improved clinical outcome after widespread use of coronary-artery stenting in CanadaJ M Rankin, J J Spinelli, R G Carere, et al.
Cancer|March 28, 2009
Educational outcomes among survivors of childhood cancer in British Columbia, Canada: report of the Childhood/Adolescent/Young Adult Cancer Survivors (CAYACS) ProgramMaria Lorenzi, Amy J McMillan, Linda S Siegel, et al.
The Journal of Allergy and Clinical Immunology|July 11, 2000
Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severityA J Sandford, T Chagani, S Zhu, et al.
Pageof 41

Showing results (271-280 of 407) with videos related to

Sort By:
Pageof 41
International Journal of Cancer|March 15, 1989
Pathologic prognostic factors for cutaneous malignant melanoma: the Western Canada Melanoma StudyA J Worth, R P Gallagher, J M Elwood, et al.
JAMA Network Open|December 7, 2020
Trends in Diagnosis Related Groups for Inpatient Admissions and Associated Changes in Payment From 2012 to 2016Ty J Gluckman, Kateri J Spinelli, Mansen Wang, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Gas-chromatographic analysis of busulfan for therapeutic drug monitoringL Embree, R B Burns, J R Heggie, et al.
Blood|September 6, 2003
Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractorinessMatthew D Seftel, Gershon H Growe, Tanya Petraszko, et al.
BMC Medical Genetics|November 18, 2009
Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphomaJohanna M Schuetz, Amy C MaCarthur, Stephen Leach, et al.
American Journal of Industrial Medicine|July 8, 2010
Exposure to anesthetic gases and congenital anomalies in offspring of female registered nursesKay Teschke, Zenaida Abanto, Laura Arbour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancyG L Phillips, J D Shepherd, M J Barnett, et al.
The New England Journal of Medicine|December 23, 1999
Improved clinical outcome after widespread use of coronary-artery stenting in CanadaJ M Rankin, J J Spinelli, R G Carere, et al.
Cancer|March 28, 2009
Educational outcomes among survivors of childhood cancer in British Columbia, Canada: report of the Childhood/Adolescent/Young Adult Cancer Survivors (CAYACS) ProgramMaria Lorenzi, Amy J McMillan, Linda S Siegel, et al.
The Journal of Allergy and Clinical Immunology|July 11, 2000
Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severityA J Sandford, T Chagani, S Zhu, et al.
Pageof 41